Nanalysis Scientific Corp
XTSX:NSCI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.145
0.33
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CA |
|
Nanalysis Scientific Corp
XTSX:NSCI
|
18.4m CAD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
188.6B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.9B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
138.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.1B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.7B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.5B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.4B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
55.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.8B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37.5B USD |
Loading...
|
Market Distribution
| Min | -4 710 029.9% |
| 30th Percentile | -65.8% |
| Median | -2.4% |
| 70th Percentile | 11% |
| Max | 71 100% |
Other Profitability Ratios
Nanalysis Scientific Corp
Glance View
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-29. The firm operates through three segments: Nanalysis, RS2D and Corporate. Through its European subsidiary RS2D S.A.S. (RS2D), the Company also manufactures and distributes electronic boards and software are used in nuclear magnetic resonance (NMR) and MRI equipment. Its 60 and 100 megahertz (MHz) spectrometers incorporate permanent magnets and require no liquid helium or other cryogens. Its spectrometers are used by chemical professionals spanning industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology. The Company’s product offerings are based upon its magnet technology, as well as its Cam4 technology.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Nanalysis Scientific Corp is -9%, which is above its 3-year median of -31.9%.
Over the last 3 years, Nanalysis Scientific Corp’s Operating Margin has increased from -27.6% to -9%. During this period, it reached a low of -67.9% on Sep 30, 2023 and a high of -6.2% on Mar 31, 2025.